The Diagnostics program focuses on the development of diagnostic tests and devices for early detection and monitoring of premorbid conditions and diseases, utilizing existing and/or novel technologies. Development of diagnostic tests for priority diseases can help follow the spread of diseases, monitor the effectiveness of interventions and indicate the presence of drug resistance.


Schist-On-Site™ and Lept-On-Site™


loT-Based Orvicidal-Larvicidal (OL) Trap and Community Dengue Early Warning System (C-DEWS)


GenAmplify™ COVID-19 rT-PCR Detection Kit


Biotek M:Dengue Detection Kit

Skip to content
Verified by MonsterInsights